Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study

Ujjwal Mukund Mahajan, Bettina Oehrle, Elisabetta Goni, Oliver Strobel, Jörg Kaiser, Robert Grützmann, Jens Werner, Helmut Friess, Thomas M. Gress, T Seufferlein, Waldemar Uhl, Uwe Will, John P. Neoptolemos, Uwe A. Wittel, Marlies Vornhülz, Simon Sirtl, Georg Beyer, Ivonne Regel, Stefan Boeck, Volker Heinemann, Fabian Frost, Antje Steveling, Henry Völzke, Astrid Petersmann, Matthias Nauck, Eckhard Weber, Beate Kamlage, Markus M. Lerch, Julia Mayerle, Ali-Alexander Aghdassi, Peter Simon, Frank-Ulrich Weiss, Matthias Sendler, Maximilian Brunner, Daniel Reim, Markus W. Büchler, Thilo Hackert, Tobias Grote, Alexander Kleger, Thomas Ettrich, Angelika Kestler, Wolff Schmiegel, Michael Pohl, Deepak Vangala, Albrecht Hoffmeister, Arndt Vogel, Heiner Wedemeyer, Chris Braumann, Patrick Michl, Jonas Rosendahl, Jakob R. Izbicki, Jochen Hampe, Stefan Sulk, Sebastian Zeissig, Andreas Stallmach, Stephan Kruger, Malte Schirren, Jan D'Haese, Martin Fuchs, Wolfgang Schepp, Marcus Bahra, Johann Pratschke, Viliam Masaryk, Markus Dollhopf, Maximilian Reichert, Ingo Klein, Jochen Wedemeyer